| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. (ROIV) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 25 sells. ROIV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.08B | - | |
| 10% | 34.49M | $1.24B | - | |
| Pres | 18.68M | $673.14M | - | |
| CEO | 16.74M | $603.17M | - | |
| Dir | 13.69M | $493.36M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Ramaswamy Vivek | 10% Owner | Sale+OE | 3,103,745 | $21.89 | $67,942,351.81 | -2.9% | +29.1% | - | |
| Dec 12, 2025 | Roivant Sciences Ltd.78 | Director, 10% Owner | Buy | 16,666,666 | $21.00 | $349,999,986.00 | +17.2% | +29.2% | - | |
| Dec 9, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $20.85 | $4,170,000.00 | -11.8% | +44.5% | - | |
| Nov 19, 2025 | Manchester Keith S49 | Director | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | +33.2% | - | |
| Nov 19, 2025 | Qvt Financial LP74 | Director By Deputization | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | +33.2% | - | |
| Nov 19, 2025 | Gold Daniel Allen73 | Director | Sell | 1,300,000 | $20.23 | $26,304,500.00 | -1.7% | +33.2% | - | |
| Nov 17, 2025 | Ramaswamy Vivek | 10% Owner | Sell | 1,854,603 | $20.46 | $37,939,111.83 | -1.8% | +31.8% | - | |
| Nov 7, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 200,000 | $20.22 | $4,044,000.00 | -11.7% | +2.5% | - | |
| Oct 17, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 851,383 | $16.99 | $14,467,502.37 | -15.9% | +35.0% | - | |
| Oct 13, 2025 | Venker Eric | President &Immunovant CEO | Sale+OE | 125,667 | $16.29 | $2,047,335.75 | -4.0% | +36.7% | - |